Background illustration for clinical trials search

Chronic Lymphocytic Leukemia Clinical Trials

Browse 1,522 chronic lymphocytic leukemia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

for
Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma,
Location: Boston MA, New York NY, Fairfax VA, Durham NC,
Sponsor: Plexium, Inc.

Sex: All

Age: 18+

Code: NCT07284186

Phase 1, Recruiting

FOCUS for Pediatric Sickle Cell Disease and Cancer

for
Pediatric Cancer, Sickle Cell Disease, Quality of Life,
Location: Atlanta GA
Sponsor: Georgia State University

Sex: All

Age: 12 - 18

Code: NCT04075877

Recruiting

Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer

for
Stage 1 cT1b-T1cN0M0, Triple Negative Breast Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06318897

Phase 2, Recruiting

QTX3034 in Patients With KRAS G12D Mutation

for
Solid Tumors
Location: New Haven CT, The Bronx NY, New York NY, Fairfax VA,
Sponsor: Quanta Therapeutics

Sex: All

Age: 18+

Code: NCT06227377

Phase 1, Recruiting

A Phase I Open-Label, Single-Arm, Dose-Escalation Clinical and Pharmacology Study of CCI-001 as Monotherapy and in Combination With Standard Chemotherapy in Patients With Recurrent and/or Metastatic Solid Tumours

for
Cancer: Recurrent and/or Metastatic Solid Tumours
Location: Edmonton
Sponsor: PharmaMatrix Holdings Ltd

Sex: All

Age: 18+

Code: NCT04823897

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies

for
Cancer
Location: Lexington KY
Sponsor: Rachel Miller

Sex: All

Age: 18+

Code: NCT03089554

Phase 2, Recruiting

A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)

for
Neoplasm Malignant
Location: New Brunswick NJ, Montreal, Baltimore MD, Ottawa,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07209111

Phase 2, Recruiting

A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications.

for
Cancer, Immunotherapy, PD-1, PD-L1, Immune Checkpoint Therapy
Location: Norwich CT, Rock Hill SC, Dublin GA
Sponsor: Oxford Biodynamics Inc.

Sex: All

Age: 18+

Code: NCT06635954

Recruiting

A Phase 1, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, and Clinical Activity of CBX-663 in Participants With Relapsed or Refractory Myeloid Malignancies, Advanced Solid Tumors, or Recurrent or Progressive Glioblastoma.

for
Advanced Solid Tumors, Recurrent or Progressive Glioblastoma,
Location: Fairfax VA, Tampa FL, Houston TX, Duarte CA
Sponsor: Crossbow Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07779798

Phase 1, Recruiting

Ex-vivo Delivery of Rituximab to Prevent PTLD in EBV Mismatch Lung Transplant Recipients: A Pilot Trial

for
Epstein-Barr Virus Infections,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT04507477

Phase 1, Phase 2, Recruiting

Norris ORIEN Total Cancer Care

for
Cancer Risk, Malignant Neoplasm
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 18+

Code: NCT02970045

Recruiting

A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

for
Primary Extra-cranial Solid Tumor,
Location: Boston MA, New York NY, Atlanta GA, Cincinnati OH,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 1 - 21

Code: NCT04928677

Phase 1, Recruiting

Evaluation of Pain Location, Pain Quality and Pain Patterns in Subjects With Chronic Pain

for
PAIN, CHRONIC DISEASE
Location: New York NY
Sponsor: Taylor MicroTechnology

Sex: All

Age: 18+

Code: NCT00284245

Recruiting

Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic Cancer

for
Cancer Metastatic, Metastatic Solid Tumor
Location: Paramus NJ
Sponsor: Valley Health System

Sex: All

Age: 18 - 70+

Code: NCT05232409

Phase 1, Recruiting

A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy

for
Advanced Solid Tumors
Location: Fairfax VA, Huntersville NC, San Antonio TX
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07161414

Phase 1, Recruiting

Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors

for
Cancer, Metastatic Cancer, Locally Advanced,
Location: Cincinnati OH
Sponsor: University of Cincinnati

Sex: All

Age: 18+

Code: NCT06416007

Phase 2, Recruiting

CIBMTR Research Database

for
Autologous Stem Cell Transplantation,
Location: Milwaukee WI, Minneapolis MN
Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All

Age: 0+

Code: NCT01166009

Recruiting

Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer

for
Cancer
Location: Burlington VT
Sponsor: University of Vermont

Sex: All

Age: 18+

Code: NCT01148407

Recruiting

A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors

for
Solid Tumor, Adult, Colorectal Cancer,
Location: Houston TX
Sponsor: Crossignal Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06598007

Phase 1, Phase 2, Recruiting

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

for
Glioma, Hematopoietic and Lymphoid Cell Neoplasm,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0+

Code: NCT01772771

Recruiting

What is chronic lymphocytic leukemia?

Chronic lymphocytic leukemia, or CLL, is a slow growing cancer of B lymphocytes that build up in the blood, bone marrow, and lymph nodes. Most people are diagnosed around age 70, often with no symptoms; when symptoms come, they include tiredness, swollen lymph nodes, frequent infections, night sweats, and weight loss. Small lymphocytic lymphoma is the same disease when the cells sit mainly in lymph nodes, so it is studied in the same trials.

When treatment is needed, it is now mostly targeted pills: BTK inhibitors taken continuously, or venetoclax based combinations taken for a fixed time. CAR T cell therapy was approved for CLL in 2024 for people whose disease has stopped responding to both. Genetic features such as TP53 mutation, deletion 17p, and IGHV status strongly predict how CLL behaves and which trials fit. Other leukemias are on our leukemia clinical trials page.

Types of CLL clinical trials

Who can participate in CLL clinical trials?

How CLL is staged, and why it matters for trials

How to enroll in a CLL clinical trial